4processed
Form 4 — Insider Transaction
Acrivon Therapeutics, Inc.(ACRV)
Filing Date
May 14, 2026
Accepted
May 14, 2026
Accession No.
0000905148-26-002502
CIK
0001781174
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Peterson Katharine | Chief Accounting Officer | Other | 99 | $1.92 | — | 3.9K | Common Stock | May 14, 2026 |